ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Diisopropylethylamine → 2-(4-Fluorophenyl)-6-(n-(2-hydroxyethyl)methylsulfonamido)-n-methyl-5-(3-(1-(pyridin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide

HRID 1025109
ノート
印刷プレビュー

反応式

HRID 1025109 の反応式
Cl.Cl.[N:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[C:9]1([NH2:12])[CH2:11][CH2:10]1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.[F:46][C:47]1[CH:52]=[CH:51][C:50]([C:53]2[O:54][C:55]3[CH:65]=[C:64]([N:66]([CH2:71][CH2:72][OH:73])[S:67]([CH3:70])(=[O:69])=[O:68])[C:63]([C:74]4[CH:75]=[C:76]([CH:80]=[CH:81][CH:82]=4)[C:77](O)=[O:78])=[CH:62][C:56]=3[C:57]=2[C:58](=[O:61])[NH:59][CH3:60])=[CH:49][CH:48]=1>CN(C=O)C.CCOC(C)=O>[F:46][C:47]1[CH:52]=[CH:51][C:50]([C:53]2[O:54][C:55]3[CH:65]=[C:64]([N:66]([CH2:71][CH2:72][OH:73])[S:67]([CH3:70])(=[O:69])=[O:68])[C:63]([C:74]4[CH:82]=[CH:81][CH:80]=[C:76]([C:77](=[O:78])[NH:12][C:9]5([C:4]6[CH:5]=[CH:6][CH:7]=[CH:8][N:3]=6)[CH2:11][CH2:10]5)[CH:75]=4)=[CH:62][C:56]=3[C:57]=2[C:58]([NH:59][CH3:60])=[O:61])=[CH:49][CH:48]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 533931811-(2-Pyridyl)cyclopropylamine DihydrochlorideHCID 59275652HCID 59275652、化合物

生成物 1

HCID 59275584
2-(4-Fluorophenyl)-6-(n-(2-hydroxyethyl)methylsulfonamido)-n-methyl-5-(3-(1-(pyridin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide
収率 32.8%

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 8857Ethyl Acetate溶媒

実験手順

1-(pyridin-2-yl)cyclopropanamine dihydrochloride (24 mg, 0.114 mmol) was added to a stirring solution of HATU (54 mg, 0.142 mmol), DIEA (50 μL, 0.285 mmol), and 3-(2-(4-fluorophenyl)-6-(N-(2-hydroxyethyl)methylsulfonamido)-3-(methylcarbamoyl)benzofuran-5-yl)benzoic acid (50 mg, 0.095 mmol) in DMF (950 μL) at rt. It was allowed to stir for 1 hour. The mixture was diluted with EtOAc and washed with sat NaHCO3, and sat NaCl. The organic phase was dried over Na2SO4, filtered and concentrated and was purified by preparative reverse phase HPLC on a C18 column using a suitably buffered H2O/CH3CN gradient, and concentrated to give the titled compound (20 mg, 32%). 1H NMR (500 MHz, DMSO-d6) d ppm 9.20 (1 H, s), 8.49-8.57 (1 H, m), 8.45 (1 H, d, J=3.97 Hz), 7.97-8.05 (3 H, m), 7.96 (1 H, s), 7.94 (1 H, d, J=7.93 Hz), 7.80 (1 H, d, J=7.93 Hz), 7.64-7.69 (1 H, m), 7.63 (1 H, s), 7.56 (1 H, t, J=7.63 Hz), 7.37-7.47 (3 H, m), 7.15 (1 H, dd, J=6.41, 4.88 Hz), 4.91 (1 H, br. s.), 3.51-3.60 (1 H, m), 3.22 (3 H, s), 2.89-2.98 (3 H, m), 2.81 (3 H, d), 1.50-1.60 (2 H, m), 1.23-1.33 (2 H, m). LC-MS retention time: 1.37 min; m/z (MH+): 643. LC data was recorded on a Shimadzu LC-10AS liquid chromatograph equipped with a Waters XBridge 5 u C18 4.6×50 mm column using a SPD-10AV UV-V is detector at a detector wave length of 220 nM. The elution conditions employed a flow rate of 5 ml/min, a gradient of 100% solvent A/0% solvent B to 0% solvent A/100% solvent B, a gradient time of 2 min, a hold time of 1 min, and an analysis time of 3 min where solvent A was 5% acetonitrile/95% H2O/10 mM ammonium acetate and solvent B was 5% H2O/95% acetonitrile/10 mM ammonium acetate. MS data was determined using a Micromass Platform for LC in electrospray mode. Additional HPLC method: Solvent A=5% CH3CN/95% H2O/0.1% TFA, Solvent B=95% CH3CN/5% H2O/0.1% TFA, Start % B=10, Final % B=100, Gradient time=15 min, Stop time=18 min, Flow Rate=1 ml/min. Column: Waters Sunfire C-18, 4.6×150 mm, 3.5 mm, Rt=7.17 min, purity=98%; Column: Waters Xbridge Phenyl column 4 6×150 mm, 3.5 mm, Rt=7.89 min, purity=99%.

後処理

  1. washwashed
  2. dry with materialThe organic phase was dried over Na2SO4
  3. filtrationfiltered
  4. concentrationconcentrated
  5. customwas purified by preparative reverse phase HPLC on a C18 column
  6. concentrationconcentrated

出典と根拠

ORDレコード
ord-1159f8a3af8b4574ac70ff363e284ae5
出典データセット
uspto-grants-2014_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08722688B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート